Article Text

Download PDFPDF
CYP1A1 and CYP2D6 Gene Polymorphisms in Israeli Jewish Women With Cervical Cancer
  1. Guy Gutman, MD*,
  2. Tova Morad, MSc,
  3. Ben Peleg, BSc*,
  4. Chavah Peretz, PhD,
  5. Amiram Bar-Am, MD*,
  6. Tamar Safra, MD and
  7. Dan Grisaru, MD, PhD*
  1. *Department of Obstetrics and Gynecology,
  2. Biochemistry Laboratory, and
  3. Oncology Division, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
  1. Address correspondence and reprint requests to Dan Grisaru MD, PhD, Gynecologic Oncology Service, Tel-Aviv Sourasky Medical Center, 6Weizman St, Tel-Aviv 64239, Israel. E-mail: grisaro{at}


Hypothesis: To assess the frequency distribution of the CYP1A1 and CYP2D6 gene polymorphisms in Israeli Jewish women with cervical cancer.

Methods: Forty-three Israeli Jewish women with cervical cancer and 123 healthy Israeli Jewish women were assessed. CYP1A1 (2 alleles) and CYP2D6 polymorphism was analyzed using an allele-specific, polymerase chain reaction-based method.

Results: The allele frequency and genotype distribution for the CYP1A1 (2 alleles) and CYP2D6 polymorphism did not reach a level of significance. Smoking was the only independent risk factor for cervical cancer (P = 0.0003).

Conclusion: CYP1A1 and CYP2D6 mutations are not related to an increased risk for cervical cancer in the Jewish Israeli population.

  • Cervical cancer
  • CYP
  • Gene polymorphism

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.